Aimovig: A Breakthrough Migraine Medication

Print icon

A new medication recently approved by the FDA for the prevention of migraine headache is offering promising results for patients who suffer from these debilitating headaches. Dr. Abigail Chua, a neurologist and headache specialist at the Hartford HealthCare Headache Center has more on this groundbreaking new therapy. 

Q: Tell us about the recent FDA-approved medication for migraine treatment.

A: Aimovig is a migraine treatment in a new class of medications called CGRP monoclonal antibodies. This medication has been FDA-approved for the preventive treatment of migraine, and acts by blocking the activity of calcitonin gene-related peptide, a molecule that is involved in migraine attacks.

Q: Why is this medication unique?

Prior to the development of CGRP-monoclonal antibodies, all of the preventives we were using for migraine were originally developed to treat other medical conditions, such as high blood pressure, depression, and epilepsy. While these medications can certainly be effective for a lot of people with migraine, not everyone can tolerate these medications, and some get no relief from them at all. Aimovig is the first medication available on the market that is designed to specifically target a protein that has been shown to be very closely tied to the development of migraine headaches.

Q: What type of patient would benefit most from this medication?

Patients who have migraine and have tried at least 2 other preventive treatments for migraine may be qualified to try this new medication.

Q: What kind of benefit can people expect from this new medication?

Aimovig is a migraine preventive treatment, and the goal of all migraine preventives is to decrease the frequency, severity, or duration of headaches. Depending on how often a person is having headaches, they may see a decrease in their headache frequency anywhere from 2 to 8 days per month, on average. Over the course of 12 months, this can mean 24 to 100 headache-free days per year.

For more information about the personalized migraine and head pain treatment available at Hartford HealthCare Headache Center, visit here

What's New

Urinary Incontinence

After Prostate Removal: The Whys and Whats of Urinary Incontinence

A radical prostatectomy that removes the prostate gland and surrounding tissue offers men with localized prostate cancer a clear pathway to neutralizing the disease. The 10-year survival rate, according to a study cited by the National Institutes of Health, is 75 percent. Urinary incontinence, or leaking urine, is a potential...

Art Therapy

ART for Healing: Coping With Cancer Through Artistic Expression

When coping with a chronic illness such as cancer, patients and their caregivers can experience a range of complex emotions. Expressive arts and other forms of integrative medicine can be an important resource for people to learn coping strategies, express their feelings and help process experiences during early diagnosis, treatment and...

Mulberry Gardens Pageant Showcases Older women’s Lives and Legacies

Words of wisdom, gleaned from years of life experiences, were freely shared and taken to heart at the Ms. Senior Mulberry Gardens Pageant 2019 held June 14 at the independent and assisted living community. “Look on the bright side,” “Do whatever you can possibly do,” “Stay active and exercise,” “Live...

Men: Take Charge of Your Health (It’s Easy)

Dr. Jared Bieniek Medical Director Hartford HealthCare Tallwood Urology and Kidney Institute Men’s Health Waiting for your car to break down is the wrong time for a tune-up.  Preventive care can keep the engine running efficiently, avoiding headaches and expensive bills.  Unfortunately, many men do not care for their health...

New Study Shows Safety in Taking Blood Thinners Before Eye Surgery

Up until recently, doctors had no idea if people who needed eye surgery but were on blood thinners could continue taking their medication safely prior to their procedure. Many patients receive a nerve block on their eye and it was unclear if patients needed to stop taking them before receiving...

Deep Brain Stimulation

After Deep Brain Stimulation, Parkinson’s Patient Playing Banjo Again

Paul Cochrane hadn’t picked up his banjo in years, ever since Parkinson’s disease had caused tremors that prevented his fingers from plucking the strings to any semblance of a tune. But, after having the Vercise Gevia Deep Brain Stimulation (DBS) battery implanted in January and turned and adjusted over the...